ClinConnect ClinConnect Logo
Search / Trial NCT06529211

Effect of Ultrasound Cavitation Versus Whole Body Vibration on Abdominal Fat in Obese Adolescent Females

Launched by CAIRO UNIVERSITY · Jul 26, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is designed to compare two different treatments—ultrasound cavitation and whole-body vibration—to see which one is more effective at reducing abdominal fat in overweight teenage girls. The study will focus on girls aged 17 to 25 who have a higher amount of fat around their waist and meet specific health criteria.

To be eligible for this trial, participants must be female adolescents with a body mass index (BMI) between 30 and 35, a waist measurement greater than 88 cm, and a waist-to-hip ratio above 0.88. However, girls with certain health issues, such as thyroid problems, diabetes, or recent surgeries involving the abdomen, will not be included. If you or someone you know fits these criteria and is interested, this study could offer an opportunity to learn about effective ways to manage abdominal obesity. Participants can expect to undergo one of the two treatments and contribute to important research that could help others in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Adolescent females suffer from abdominal obesity.
  • Their ages will be ranged from 17 to 25 years old.
  • Their body mass index (BMI) will be ranged from 30 to 35 kg/m2.
  • Their waist circumference will be \> 88 cm.
  • Their WHR will be more than 0.88.
  • Exclusion Criteria:
  • Females will be excluded from the study if they have:
  • Thyroid, hepatic and kidney disorders.
  • Diabetes mellitus, coronary artery diseases, hypertension and congestive heart failure.
  • Recent abdominal surgical scar or umbilical hernia.
  • History of orthopedic implants insertion or cardiac pacemaker implantation.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Trial Officials

Azza Kassab

Study Chair

Cairo University

Manal El-Shafei

Study Director

Cairo University

Mohamed AboEleinen

Study Director

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported